Contents & References of Investigating the effect of polyvinylpyrrolidene (pvp) surfactant concentration on the size of nanoparticles in the process of nanomedicine production using anti-solvent solvent precipitation method in microchannels
List:
Abstract: 1
Introduction: 1
Chapter One: General Research
1-1: Introducing curcumin. 4
1-2: Chemical compounds of turmeric. 5
1-3: Medicinal properties of turmeric. 6
1-4: Medicinal nanocrystals. 7
1-5: Microchannels 7
1-6: Particle size: 12
1-6-1: Description of methods for measuring and analyzing particle size distribution in a suspension or emulsion solution: 12
1-6-2: Measurement of particle size distribution. 13
1-6-3: Projection of particle size distribution. 14
1-6-4: Receptor size of nano particles. 16
1-7: Zeta potential 17
1-8: XRD test. 18
1-9: Scanning electron microscope. 19
1-9-1: Scanning electron microscope and its history. 19
1-9-2: History. 19
1-9-3: Familiarity with scanning electron microscope. 20
1-9-4: General uses. 20
1-9-5: Examples of the application of 21
1-9-6: Sample sizes 22
1-9-7: preparation 22
1-9-8: Chemical analysis in electron microscopy. 23
1-9-9: Limitations 23
1-10: freeze dryer 24
1-11: What is a spectrophotometer? 25
1-12: FTIR test. 26
1-13: The process of ultrasonic waves. 27
1-14: Surface area measurement test. 27
1-15: Solvent / anti-solvent deposition process. 28
1-16: The necessity of using the solvent/anti-solvent precipitation method and its advantages. 28
The second chapter: An overview of research literature and research background
2-1: An overview of previous research in the field of drug production 33
2-2: Medicinal plants produced using nanotechnology. 37
2-2-1: Hydrogen peroxide. 37
2-2-2: Katira medicinal plant in nanotechnology. 38
3-1: solution 43
3-2: Surfactant 43
3-3: Preparation of curcumin solution. 47
3-4: Preparation of surfactant solution. 49
3-5: Test steps. 49
Chapter Four: Results and discussion
4-1: Particle size measurement results. 58
4-2: Measurement results of zeta potential 60
4-3: XRD test results. 62
4-4: SEM test results. 64
4-5: FTIR test results. 65
4-6: Surface area measurement test results. 69
The fifth chapter: Summary and suggestions
5-1: Summary. 72
2-5: Suggestions 73
Source:
A. P. V. Date., 2004. "Current strategies for engineering drug nanoparticles" Curr. Opin. Colloid Interface Sci, pp. 222-235.
V. D. A. K. R. Patravale., 2004. "Nanosuspensions: a promising drug delivery strategy" J. Pharm. Pharmacol. 56, p. 827–840.
R. Muller, C. Jacobs and O. Kayser., 2001. "Nanosuspensions as particulate drug formulation in therapy rationale for development and what we can expect for the future" AdV. Drug Delivery Rev., 47, pp. 3-19.
E. Merisko-Liversidge, G. G. Liversidge and E. R. Cooper., 2003. "Nanosizing a formulation approach for poorly-water-soluble compounds," Eur. J. Pharm. Sci., 18 (2), pp. 113-120,
P. Anand, A. B. Kunnumakkara, R. A. Newman and B. B. Aggarwal., 2007. Mol. Pharmaceutics, 4, p. 807–818.
V. D. A. K. R. Patravale., 2004. "Nanosuspensions: a promising drug delivery strategy" J. Pharm. Pharmacol. 56, p. 827–840.
J. F. Chen, C. Zheng and G. T. Chen., 1996. "Interaction of macro- and micromixing on particle size distribution in reactive precipitation" Chem. Eng. Sci., pp. 1966-1957.
G. B. G. C. S. Parsons., 1992. "The use of surface energy and polarity determinations to predict physical stability of non-polar, non-aqueous suspensions" Int. J. Pharm. 83, p. 163–170.
K. J. Brian and K. P. Robert., 2003 "Chemical processing and micromixing in confined impinging jets" AIChE J., 49 (9), pp. 2264-2282.
X. ]: Li, J. F. Chen and G. T. Chen., 1994. "Morphological configurations of material elements during turbulent mixing, experimental study and modeling" Acta Mech. Sin., 26 (3), pp. 266-274.
J. D.R.A. Petros., 2010. "Strategies in the design of nanoparticles for therapeutic applications". "Strategies in the design of nanoparticles for therapeutic applications" Nat. Rev. Drug Discov, p. 615–627.
V. K. LaMer and R. H. Dinegar., 1950 "Production Theory and Mechanism of Formation of Monodispersed Hydrosols" J. Am. Chem. Soc., 72, pp. 4847-4854.
J. F. Chen, Y. H. Wang, F. Guo, X. M. Wang and C. Zheng.,2000."Synthesis of Nanoparticles with Novel Technology: High-Gravity Reactive Precipitation" Ind. Eng. Chem. Res., 39, pp. 948-954.
J. A. Dirksen and T. A. Ring., 1991. "Fundamentals of Crystallization: Kinetic Effects on Particle Size Distributions and Morphology" Chem. Eng. Sci. , 46, pp. 2389-2427.
E. D. F. D. M. C. N. Dudognon., 2008. "Evidence for a new crystalline phase of racemic ibuprofen" Pharm. Res. 25, p. 2853–2858.
J. C. J. P. C. Lee., 2008 "Characteristics of polymers enabling nanocomminution of water-insoluble drugs" Int. J. Pharm. 355, p. 328–336.
V. D. A. K. R. Patravale., 2004 "Nanosuspensions: a promising drug delivery strategy" J. Pharm. Pharmacol. 56, p. 827–840.
D. K. C. G. A. S. S. H. M. S. P. C. Z. W. J. Wishart., 2006 "Drug bank: a comprehensive resource for in silico drug discovery and exploration" Nucleic Acids Res. 34, p. D668–D672.
T. Sugimoto., 2003 "Formation of Monodispersed Nano- and Micro Particles Controlled in Size, Shape, and Internal Structure" Chem. Eng. Technol., 26 (3), pp. 313-321.
B. L. Cushing, V. L. Kolesnichenko and C. J. O'Connor., 2004 "Recent advances in the liquid-phase syntheses of inorganic nanoparticles" Chem. ReV., 104 (9), pp. 3893-3946.
R. B. J. L. J. Williams III., 1999. "Influence of micronization method on the performance of a triamcinolone acetonide suspension pressurized metered dose inhaler formulation" Pharm. Dev. Technol. 4, p. 167-179.
N. Rasenack and B. W. Mu¨ller., 2002. "Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs" Pharm. Res., 19, pp. 1894-1900.
J. H. Hu, K. P. Johnston and R. O. Williams., 2004. "Rapid dissolving high potency danazol powders produced by spray freezing into liquid process" Int. J. Pharm., 271 (1-2), pp. 145-154.
T. L. Rogers, K. P. Johnston and Williams R. O., , 2001. "Solution Based Particle Formation of Pharmaceutical Powders by Supercritical or Compressed Fluid CO2 and Cryogenic Spray-Freezing Technologies" Drug DeV.Ind. Pharm., 27, pp. 1003-1015.
C. Jacobs, O. Kayser and R. H. Muller., 2000. "Nanosuspensions as a new approach for the formulation for the poorly soluble drug tarazepide" Int. J. Pharm., 196, pp. 161-164.
J. F. Chen, J. Y. Zhang, Z. G. Shen, J. Zhong and J. Yun., 2006. "Preparation and Characterization of Amorphous Cefuroxime Axetil Drug Nanoparticles with Novel Technology: High-Gravity Antisolvent Precipitation" Ind. Eng. Chem. Res., 45 (25), pp. 8723-8727.
E. Reverchon, I. De Marco and G. Della Porta., 2002. "Rifampicin microparticles production by supercritical antisolvent precipitation" Int. J. Pharm. 2002, 243 (1-2), pp. 83-91.
F. Francesco, H. Markus and M. Marco., 2005. "Dense Gas Antisolvent Precipitation: A Comparative Investigation of the GAS and PCA Techniques," Ind. Eng. Chem. Res., 44 (5), pp. 1502-1509.
P. H.L.S.J.B.G.P.M.A. Smith., 1997. "Widespread peroxynitrite-mediated damage in Alzheimer's disease" J. Neurosci. 17, p. 2653–2657.
W. G. C. N. Ramakrishna., 1992. "Radioprotection of hematopoietic tissues in mice by lipoic acid" Rad. Res. 130, p. 360–365.
G. L. D. M. A. M. D. P. T. T. A. El-Agamey., 2004. "Carotenoid radical chemistry and antioxidant/pro-oxidant properties" Arch. Biochem. Biophys. 430, p. 37-48.
H. G.K.H.N.M.P.M.J.L.I.D. Podmore. , 1998. "Vitamin C exhibits pro-oxidant properties," Nature 392, p. 559.
R. P.-B. D.D.R.R.L.A.E.G.E.R. Miller., 2005. "Meta-analysis: high-dosage Vitamin E supplementation may increase all-cause mortality" Ann. Intern. Med. 142, p. 37-46.
J. S.P.B.D.H.C.A.